Salem, H.F.; Abd El-Maboud, M.M.; Said, A.S.A.; Salem, M.N.; Sabry, D.; Hussain, N.; El-Ghafar, O.A.M.A.; Hussein, R.R.S.
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals 2023, 16, 60.
https://doi.org/10.3390/ph16010060
AMA Style
Salem HF, Abd El-Maboud MM, Said ASA, Salem MN, Sabry D, Hussain N, El-Ghafar OAMA, Hussein RRS.
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals. 2023; 16(1):60.
https://doi.org/10.3390/ph16010060
Chicago/Turabian Style
Salem, Heba F., Marwa Mohamed Abd El-Maboud, Amira S. A. Said, Mohamed Nabil Salem, Dina Sabry, Nadia Hussain, Omnia A. M. Abd El-Ghafar, and Raghda R. S. Hussein.
2023. "Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis" Pharmaceuticals 16, no. 1: 60.
https://doi.org/10.3390/ph16010060
APA Style
Salem, H. F., Abd El-Maboud, M. M., Said, A. S. A., Salem, M. N., Sabry, D., Hussain, N., El-Ghafar, O. A. M. A., & Hussein, R. R. S.
(2023). Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis. Pharmaceuticals, 16(1), 60.
https://doi.org/10.3390/ph16010060